Pillstats
Rx only · Tablet, Coated · Oral

Methocarbamol

Methocarbamol

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6845
US makers6 labelers
Packages15
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.40$4.80$7.20$9.60Dec 2025Feb 2026May 2026
$8.348
Latest avg · May 20, 2026
+0%
Since Dec 17, 2025
6
Active US suppliers
60%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a1.8K3.7K5.5K7.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
6.4K
Rx · 2026 Q1
490K
Units dispensed
4
Quarters · since 2025 Q2

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bostal LLCunknown6SUPPLYING
Direct_Rxunknown3SUPPLYING
Advanced Rx of Tennessee, LLCunknown3SUPPLYING
Trifluent Pharma LLCunknown1SUPPLYING
Oncora Pharma, LLCunknown1SUPPLYING
Misemer Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.